Choose Your News
Loading...
Thumbnail
ResMed has closed the acquisition of MatrixCare for $750 million in cash. MatrixCare provides software solutions for long-term care settings. The deal is a comp... [Read More]
Thumbnail
MOGU intends to raise $200 million from the sale of ADSs in a U.S. IPO. The firm operates an online fashion and accessories portal for... [Read More]
Thumbnail
Moderna has filed to raise $500 million in a very large biopharma IPO. The firm is advancing a large pipeline of mRNA-based treatments for a... [Read More]
Thumbnail
SAP intends to acquire Qualtrics for $8 billion just prior to the target's IPO. Qualtrics provides software that enables enterprises to collect and manage exper... [Read More]
Thumbnail
Legacy Housing has filed to raise $69 million in a U.S. IPO. The firm builds and provides financing for manufactured homes and tiny houses for... [Read More]
Thumbnail
Weidai has filed proposed terms for a $45 million U.S. IPO of its ADSs. The firm operates an online marketplace that connects Chinese borrowers with... [Read More]
Thumbnail
Marchex has acquired Telmetrics for up to $13.6 million in cash and RSUs. Telmetrics provides enterprises with a real-time call and SMS/text tracking and analyt... [Read More]
Thumbnail
RTI Surgical intends to acquire Paradigm Spine for up to $300 million in cash and stock. Paradigm has developed a non-fusion spinal implant device for... [Read More]
Thumbnail
TuanChe intends to sell $34 million of ADSs in a U.S. IPO. The firm provides an online automobile sales platform combined with offline group sales... [Read More]
Sutro Biopharma intends to raise at least $75 million from the sale of its common stock in a U.S. IPO. The firm is advancing a... [Read More]
Capital Bancorp and shareholders intend to sell $30 million of common stock in an IPO. The firm operates a community bank in the Washington, DC... [Read More]
Gritstone Oncology intends to raise $85 million from the sale of its common stock in an IPO. The firm is advancing immunotherapy-based cancer treatments using... [Read More]
CooTek has filed proposed terms to sell $57 million of ADSs representing Class A shares in a U.S. IPO. The firm is a mobile app... [Read More]
Arvinas Holding aims to sell $100 million of its common stock in a U.S. IPO. The firm is advancing a pipeline of drug candidates for... [Read More]
Entasis Therapeutics has lowered its sights slightly and intends to raise $75 million in a U.S. IPO. The firm is advancing a pipeline of drug... [Read More]
Equillium intends to raise $86.25 million in gross proceeds from a U.S. IPO. The firm is advancing its EQ001 treatment candidate through early stage trials.... [Read More]
Ra Medical intends to raise $50 million in an IPO of its common stock. The firm is commercializing a new vascular treatment system for Peripheral... [Read More]
Osmotica Pharmaceuticals aims to raise $100 million in an IPO of its common stock. The firm sells generic drugs, has proprietary controlled release technologies... [Read More]
Anaplan aims to raise $100 million or more in an IPO of its common stock. The firm provides large enterprises with a cloud-based resource planning... [Read More]
Urovant Sciences has filed proposed terms for its $150 million IPO. The firm is pursuing mid- to late-stage trials for Vibegron, a treatment candidate for... [Read More]
Loading...
Preview